Heaven’s Beverley Mitchell reflected on a life-changing experience when doctors found the “biggest precancerous polyp” on her ...
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:00 AM EDTCompany ParticipantsMark Stolper - Executive VP ...
Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now ...
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Dig ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ultrasound system at the Esaote booth ...
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results